Our results of both in vivo and in vitro experiments showed that metformin restrained hypoxia-induced excessive angiogenesis in PNR by suppressing HIF-1α-induced pro-angiogenic factors via elevating tumor blood perfusion. This evidence concerns the gene HIF1A and neoplasm.